Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent

PHASE4CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2013

Conditions
Coronary Heart Disease
Interventions
DEVICE

Helistent Titan2 (Titanium coated stent)

Titan2

DEVICE

EndeavorTM (Zotarolimus-Eluting Stent)

Endeavor

Trial Locations (1)

3010

Department of Cardiology, University Hospital Bern, Bern

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

University of Bern

OTHER

NCT00492908 - Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent | Biotech Hunter | Biotech Hunter